Full review
Chronilogix CAIHL draft report
Evidence-linked HugoScore draft report for a health AI tool that affects patients.
Agency checklist · October 30, 2026
Mixed 7 of 12 yes
Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.
Assessed function: Public descriptions of Roni and Millie, consumer app listing, institutional sales pages and published policies. No authenticated or partner deployment tested.
A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.
- Public documents do not establish actual product behavior.
- The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
| Question | Answer | Evidence / review | Source and reasoning |
|---|---|---|---|
| 1. Told it is AI | Yes | documented Not independently replicated | Chronilogix AI is an AI model powered by large language models (LLMs) and is under continuous training.Source Terms section 2.4. The App Store listing also says 'Chat with an AI-powered coach'. |
| 2. Operator and model maker named | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Operator is named: Chronilogix, Inc., Delaware, Fairfield CT (privacy policy). The terms describe 'proprietary fine-tuned AI models' and LLMs but no model maker is named. |
| 3. Patient chooses to use it | Yes | documented Not independently replicated | Sign in and choose your coachSource Consumer app path: the user downloads the app and signs in. Employer, plan and partner deployments are a separate channel and were not assessed. For those, this answer would be deployer-dependent. |
| 4. Patient sets the task | Yes | documented Not independently replicated | Chronilogix adapts its guidance based on your goals, priorities, and progress.Source The user sets goals in the consumer app. The coaching method (motivational interviewing) is fixed by the operator, and institutional buyers pitch outcomes like claims reduction, so this may differ in deployments. |
| 5. Patient can decline or stop | Yes | documented Not independently replicated | Sign in and choose your coachSource Self-started tool rule: Q3 is yes and no care depends on it for the consumer app. Source is the Q3 source. In a hybrid or plan-delivered program this could be different. |
| 6. Patient sees the AI output | Yes | documented Not independently replicated | Chat with an AI-powered coachSource The patient sees the chat directly. Privacy policy says transcripts are stored. FAQ says interactions can be summarized for a clinician. |
| 7. Patient can correct or challenge | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. The privacy policy gives a right to rectify inaccurate personal data, but nothing documents a route to correct or contest an AI coaching output. Terms section 2.4 only warns about errors. |
| 8. Patient can get a copy | Yes | documented Not independently replicated | You have the right to receive the personal data you have provided to us in a structured, commonly used, and machine-readable formatSource Privacy policy section VII, by emailing the privacy address. The right is stated as limited to consent or contract based processing. |
| 9. Patient can delete | Yes | documented Not independently replicated | If you delete your account, all associated data is permanently removed from our serversSource Section V adds 'except for aggregated and anonymized data used for AI improvement'. Conversations are kept until the user deletes them. |
| 10. Training or sale does not override patient choice | No | documented Not independently replicated | To continuously train, refine, and improve the accuracy, safety, and performance of the models and algorithms underlying Chronilogix AISource Privacy III.B and Terms 4.3 and 5.2 use aggregated, de-identified user content to train models under a perpetual license. No opt-out is documented, only a conditional right to object. The site says 'Member data is never used to train our models', which conflicts, so the binding documents govern. |
| 11. Patient can run it or take it elsewhere | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Vendor-hosted app. Portability is by email request only, and no way to run it yourself or move the function is documented. |
| 12. No advertising or data business | No | documented Not independently replicated | to serve our advertisements to you through third-party platforms such as Facebook or GoogleSource Privacy III.E and X document retargeting ads, and IV.B shares aggregated and de-identified data with analytics and advertising providers. The ads promote Chronilogix, not third parties. The policy says it does not sell personal data. |
Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.
Checklist rules · Independent review and limitations · Later evidence follow-up
Earlier report
Chronilogix: draft HugoScore review
Method v1.3 review, October 30, 2026
Agency finding: Mixed.
Control: No position: model provider not disclosed. Unresolved, toward the middle of the institutional to patient-directed line on current documents. The patient opens the app, chooses a coach and sets goals, which places the direct consumer function above the institutional end. The rails that could pull it toward that end are documented but not tied to this deployment: an operator-fixed Motivational Interviewing method whose own implementation guide has the deployer identify 'the change behavior' and track conversion, refill and retention, buyer marketing for claims mitigation and adherence, a medication-adherence thread built into the diabetes coach, and a validation layer that rewrites replies by unpublished criteria. The output license limits use to individual self-reflection with unclear scope for sharing with a clinician. Operator and model developer disclosure: the operator is named, the model developer is not, so no position or candidate set is shown (model provider not disclosed).
Disclosure (transparency gate): Service operator named: yes, in public documents. Model developer named: not found in public documents. AI names its operator when asked: not tested (documentary review).
Evidence: Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status: Human adjudication: Hugo Campos settled named questions (what was reviewed, the disclosure results, any coder disagreement). Not verification of the service's claims.
Coded by: Claude Opus 5.5 (Anthropic), coder 1, and GPT-6 Astra (OpenAI), coder 2, coded independently. Conflict check open: the model developer is not known.
What it helps a patient do
- Goal setting and step plans between visits (Act, documented, not tested). The patient can turn a broad aim into small, scheduled steps, track progress and adjust the plan with a coach available at any hour, documented in the App Store description and product page. Comparator: the patient's realistic alternative in this use is no between-visit coaching or a human coach with limited availability; the comparator itself rests on vendor statements. Operation untested.
What limits the patient
- Training use contradicted within the notice (Refuse or leave, documented, not tested). The Terms (4.3, 5.2) and Privacy Policy (III.B, V) take the user's explicit consent and a perpetual license to use anonymized, aggregated User Content to train Chronilogix AI and other Chronilogix products. The footer printed on those same Terms and Privacy pages says 'Member data is never used to train our models', and the Product page and FAQ say conversations are never 'used to improve our models'. No reachable clarification says whether 'member' excludes direct users. A patient reading the notice at entry cannot tell whether their conversations train the models. The underlying practice remains unknown. Blocks informed entry (refuse or leave).
Strongest evidence against these findings
Control: E17 is the strongest evidence that the purpose may be external. Chronilogix's own implementation guide has the deployer 'identify the change behavior' and align conversation quality with 'conversion, refill rate, retention', and the buyer pages sell claims mitigation and adherence. If the direct consumer app runs the same engine with an operator-set change target, P is external. In the other direction, the App Store flow and E18 describe patient-chosen, revisable goals. Posture: the notice contradiction could dissolve if Chronilogix shows that 'member' means sponsored enterprise users only and that a consumer-facing in-app notice states the training use clearly at entry; then only candidates of unresolved scope remain and the posture would be Unclear. Toward a more adverse finding: the output license and bundled training consent could become supported constraints if their scope is clarified against the patient.
Open questions
- Base model developer and inference host (T2, conflict check)
- Whether the direct consumer app has an operator-set change target or escalation to human clinicians
- Whether 'member' in the training statements excludes direct users
- In-app consent and notice screens
- Consumer subscription prices
- Scope of the AI Output license for private sharing with a clinician
- Criteria of the validation layer that rewrites replies
What changed from the earlier review
Same posture. The training-statement conflict the legacy report noted is now the supported constraint under the F11 notice rule, and the new transparency gate withholds any position because the base model developer is not named.
Sources
- E1: https://chronilogix.com/terms-and-conditions, The agreement; 1 Definitions ('Chronilogix, we, us, our'); last updated April 20, 2026. Retrieved 2026-10-30.
- E2: https://chronilogix.com/privacy-policy, I Overview ('Who we are (data controller)'); XII Contact us; last updated April 20, 2026. Retrieved 2026-10-30.
- E3: https://apps.apple.com/us/app/chronilogix/id6754387967, App description, Information, App Privacy, Version History. Retrieved 2026-10-30.
- E4: https://chronilogix.com/terms-and-conditions, 2.4 Limitations inherent to generative artificial intelligence; 4.1 Ownership of Chronilogix AI. Retrieved 2026-10-30.
- E5: https://chronilogix.com/resources/mi-whitepaper, PDF 'Motivational Interviewing in AI Coaches', section 10 Implementation Framework, p.15. Retrieved 2026-10-30.
- E6: https://chronilogix.com/, All surfaces listed in contentHashes. Retrieved 2026-10-30.
- E7: https://chronilogix.com/terms-and-conditions, 4.3 Ownership of User Content; 5.2 Data use for AI improvement. Retrieved 2026-10-30.
- E8: https://chronilogix.com/privacy-policy, III.B For product improvement and AI model training; V Data retention; IV.F Data we do not share. Retrieved 2026-10-30.
- E9: https://chronilogix.com/terms-and-conditions, Page footer, also on /privacy-policy, /, /faq, /product, /about. Retrieved 2026-10-30.
- E10: https://chronilogix.com/product, Privacy by design; Data Stays Yours. Retrieved 2026-10-30.
- E11: https://chronilogix.com/faq, 03 Safety & clinical oversight. Retrieved 2026-10-30.
- E12: https://chronilogix.com/terms-and-conditions, 4.4 AI Output. Retrieved 2026-10-30.
- E13: https://chronilogix.com/product, Inside one reply; The coaches; 01 MI Engine. Retrieved 2026-10-30.
- E14: https://chronilogix.com/faq, 01 About Chronilogix; 03 Safety & clinical oversight. Retrieved 2026-10-30.
- E15: https://chronilogix.com/solutions/brokers, Introducing Chronilogix; The business impact. Retrieved 2026-10-30.
- E16: https://chronilogix.com/solutions/vendors, Hero; The upgrade; also /partner-solutions. Retrieved 2026-10-30.
- E17: https://chronilogix.com/resources/mi-whitepaper, PDF sections 10 Implementation Framework, 11 Risks and Limitations, closing 'What makes us different', pp.15 to 19. Retrieved 2026-10-30.
- E18: https://chronilogix.com/about, Our values, Human dignity. Retrieved 2026-10-30.
- E19: https://chronilogix.com/terms-and-conditions, 2.2, 2.3; compared with /product sections 06 Crisis safe and Roni AI. Retrieved 2026-10-30.
- E20: https://chronilogix.com/terms-and-conditions, 10.3 Mandatory binding arbitration; 8.2 Cap on liability. Retrieved 2026-10-30.
- E21: https://chronilogix.com/privacy-policy, VII Your data protection rights. Retrieved 2026-10-30.
- E22: https://chronilogix.com/privacy-policy, III.E For analytics and research; X Cookies and other tracking technologies. Retrieved 2026-10-30.
- E23: https://chronilogix.com/terms-and-conditions, 11.3 Termination by Chronilogix; 4.2 Limited license. Retrieved 2026-10-30.
- E24: https://chronilogix.com/faq, 04 For buyers & partners. Retrieved 2026-10-30.
- E25: https://chronilogix.com/case-studies/aetna, Case study; homepage 'Proof in the field' and testimonials. Retrieved 2026-10-30.
- E26: https://chronilogix.com/terms-and-conditions, 2.5 User responsibility and discretion; 3.3. Retrieved 2026-10-30.
- E27: https://chronilogix.com/terms-and-conditions, 6.1 to 6.4; App Store listing price. Retrieved 2026-10-30.
- E28: https://chronilogix.com/terms-and-conditions, 11.2 Termination by you; Privacy Policy V Data retention. Retrieved 2026-10-30.
- E29: https://chronilogix.com/product, 02 Access; 04 Multilingual; App Store Accessibility and Languages. Retrieved 2026-10-30.
- E30: https://chronilogix.com/, Three Levels of Care; FAQ 'Is Chronilogix a good fit for seniors'. Retrieved 2026-10-30.
Earlier review, September 28, 2026
The review below was prepared on September 28, 2026 with OpenAI Codex / GPT-6 (exact variant not recorded), before method v1.3. It is kept unchanged as history. Where it differs from the v1.3 review above, the v1.3 review is current.
Review date: September 28, 2026. Status: unscored AI-assisted draft; publication authorized by Hugo Campos.
1. Executive Summary
Chronilogix offers patient-facing AI coaching with potential to support reflection and personally meaningful goals. Its institutional sales model emphasizes adherence and claims reduction. The resulting agency posture is Mixed, with patient authority in specific deployments unverified. Public disclosures contain material conflicts about model training and the service's clinical role.
2. CAIHL Question
Who does this AI serve? Patients use the coaching; employers, plans, brokers and product vendors are prominent buyers. These interests can coincide, but patient control cannot be inferred from an empathetic conversational style. Broker offering
3. What The Service Does
- Tool/vendor: Chronilogix / Chronilogix, Inc.
- URL: https://chronilogix.com/
- Category: Condition-specific coaching and care AI; mental health coaching.
- Coaches: Roni for diabetes/chronic care; Millie for mental health/mood.
- Primary users: patients or members; organizational purchasers shape deployments.
- Hosting/control: vendor-hosted, with partner embedding and a consumer app listing. Direct consumer and institutional workflows require separate assessment.
4. Patient-Impact Pathway
AI conversations may influence self-management, care-seeking and health decisions. The tool passes the AI, health and patient-impact scope gates. Potential benefits include accessible reflection and goal setting; potential constraints include institution-selected goals and unclear control over sharing and AI-created interpretations. These are plausible pathways, not observed app behavior.
5. Evidence Table
Training disclosures conflict
The FAQ excludes conversation use for model improvement. Privacy policy III.B permits training with primarily aggregated/de-identified content; V preserves anonymized improvement data after deletion. This establishes inconsistent disclosures, not proof of actual training. FAQ, Privacy
Clinical role needs clarification
The FAQ denies clinician replacement; the broker page proposes replacing up to 80% of human coaching sessions. Terms 2.1–2.3 define self-help, exclude treatment and emergency support, and describe hotline redirection. Coaching replacement and clinician replacement are not identical, but the practical boundary needs explanation. FAQ, Brokers, Terms
Headline outcome is evidence for another intervention
The homepage attributes its 58% example to the Diabetes Prevention Program. NIH confirms the intensive lifestyle intervention result. This supports the general rationale, not the effectiveness of Chronilogix; the site does not label it a Chronilogix trial. Homepage, NIDDK
Scientific association has substance but limited evidentiary reach
Minnesota independently lists Kenneth Resnicow as faculty. That confirms academic standing, not product performance. University directory
6. Mixed HugoScore Profile
Agency posture
Mixed
Classification
Hybrid; prominent institution-directed commercial deployment
Axis position
Unscored; no cross-deployment numerical placement justified
Patient visibility
Yes in reviewed public materials; embedded deployment disclosure untested
Choice and refusal
Partial: app lists adjustable goals; refusal without benefit consequences unknown
Correction and challenge
Partial: policy provides data correction rights; correction of AI interpretations untested
Action support
Potentially: reflection and goal setting; advocacy against institutional decisions not established
Equity burden
Cultural tailoring and broader access are claimed; accessibility and subgroup performance unverified
Data governance
Conversation storage; conditional access/portability rights; deletion provisions with derivative-data exception; conflicting training statements
Clinical boundaries
Partial/inconsistent across promotional and contractual material
Evaluation ownership
Vendor/scientific leadership visible; patient partnership in defining evaluation outcomes not established
Sources: Product, App Store, Privacy, About.
7. Key Unknowns
Which training statement governs each deployment? Can patients decline sponsor goals, inspect and correct inferred profiles, control clinician summaries, and leave without consequences? Who receives identifiable conversations? What are the model/provider arrangements and human escalation response times? Are product-specific trials, adverse-event results and independent MI-fidelity evaluations available? Targeted searches did not locate a peer-reviewed evaluation of the current Roni/Millie products; that is not proof none exists.
8. Patient Agency Interpretation
The decisive behavioral test is whether the coach helps a patient pursue a goal that conflicts with the purchaser's preferred outcome. Empathy and engagement alone cannot establish that authority. Cost reduction can benefit patients; it does not itself demonstrate patient alignment. Risks identified here concern opacity, expectation mismatch and possible institutional steering, not established harm.
9. Publication Recommendation
Publication authorized as an unscored, source-backed AI-assisted draft with deployment qualifications. Training and clinical-scope questions remain unresolved. Publication is not endorsement or comprehensive human verification.
Confidence: medium for documentary findings; low for actual behavior and efficacy. Review provenance: OpenAI Codex / GPT-6 (exact model variant not recorded); CAIHL and current HugoScore framework. Hugo Campos authorized publication; comprehensive human verification has not occurred. Public-source review only; no account, health-data upload, hands-on testing, security audit or vendor interview. Evidence access date: September 28, 2026.